Physical Stability of Proteins in Aqueous Solution: Mechanism and Driving Forces in Nonnative Protein Aggregation
暂无分享,去创建一个
John F. Carpenter | Theodore W. Randolph | J. Carpenter | E. Chi | S. Krishnan | T. Randolph | Eva Y. Chi | Sampathkumar Krishnan
[1] Ank Valstar. Protein-surfactant interactions , 2000 .
[2] Henry Eyring,et al. Conformation Changes of Proteins , 1954 .
[3] T. Arakawa,et al. Mechanism of protein salting in and salting out by divalent cation salts: balance between hydration and salt binding. , 1984, Biochemistry.
[4] G. Visor,et al. Stability of interleukin 1 beta (IL-1 beta) in aqueous solution: analytical methods, kinetics, products, and solution formulation implications. , 1991, Pharmaceutical research.
[5] Steven J. Prestrelski,et al. A New Strategy for Enhancing the Stability of Lyophilized Protein: The Effect of the Reconstitution Medium on Keratinocyte Growth Factor , 1995, Pharmaceutical Research.
[6] F. Gejyo,et al. Kinetic analysis of amyloid fibril formation. , 1999, Methods in enzymology.
[7] A. Grillo,et al. Conformational origin of the aggregation of recombinant human factor VIII. , 2001, Biochemistry.
[8] C. Dobson,et al. A kinetic study of β‐lactoglobulin amyloid fibril formation promoted by urea , 2002 .
[9] B. Kerwin,et al. Effects of Tween 80 and Sucrose on Acute Short-Term Stability and Long-Term Storage at − 20 C of a Recombinant Hemoglobin , 1998 .
[10] T. Arakawa,et al. Stability of recombinant consensus interferon to air-jet and ultrasonic nebulization. , 1995, Journal of pharmaceutical sciences.
[11] S. Magdassi. Surface activity of proteins : chemical and physicochemical modifications , 1996 .
[12] J. Prausnitz,et al. Protein-protein interactions in concentrated electrolyte solutions: Hofmeister-series effects , 2002 .
[13] A. Randolph,et al. Theory of Particulate Processes: Analysis and Techniques of Continuous Crystallization , 1971 .
[14] C. Pace,et al. Forces contributing to the conformational stability of proteins , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[15] Calculation of phase diagrams for aqueous protein solutions , 2001 .
[16] P. Privalov,et al. Stability of protein structure and hydrophobic interaction. , 1988, Advances in protein chemistry.
[17] P. Deluca,et al. Stability of ribonuclease A in solution and the freeze-dried state. , 1990, Journal of pharmaceutical sciences.
[18] M. Betenbaugh,et al. I. Study of protein aggregation due to heat denaturation: A structural approach using circular dichroism spectroscopy, nuclear magnetic resonance, and static light scattering. , 1998, Biotechnology and bioengineering.
[19] T. Arakawa,et al. Stabilization of protein structure by sugars. , 1982, Biochemistry.
[20] C. Ionescu-Zanetti,et al. Partially folded intermediates as critical precursors of light chain amyloid fibrils and amorphous aggregates. , 2001, Biochemistry.
[21] P E Fraser,et al. A kinetic model for amyloid formation in the prion diseases: importance of seeding. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[22] T. Arakawa,et al. Strategies to suppress aggregation of recombinant keratinocyte growth factor during liquid formulation development. , 1994, Journal of pharmaceutical sciences.
[23] Pablo G. Debenedetti,et al. Metastable Liquids: Concepts and Principles , 1996 .
[24] K. Dill. Dominant forces in protein folding. , 1990, Biochemistry.
[25] V. Uversky,et al. Effect of environmental factors on the kinetics of insulin fibril formation: elucidation of the molecular mechanism. , 2001, Biochemistry.
[26] J. King,et al. Conformation of P22 tailspike folding and aggregation intermediates probed by monoclonal antibodies , 1997, Protein science : a publication of the Protein Society.
[27] Jan Drenth,et al. Understanding protein crystallization on the basis of the phase diagram , 1999 .
[28] D. Paton,et al. Thermodynamic characterization of an intermediate state of human growth hormone , 1998, Protein science : a publication of the Protein Society.
[29] B. Chang,et al. Preferential exclusion of sucrose from recombinant interleukin-1 receptor antagonist: role in restricted conformational mobility and compaction of native state. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[30] R. Carrotta,et al. Conformational characterization of oligomeric intermediates and aggregates in β‐lactoglobulin heat aggregation , 2001, Protein science : a publication of the Protein Society.
[31] C. R. Middaugh,et al. Stabilization of proteins by low molecular weight multi-ions. , 2002, Journal of pharmaceutical sciences.
[32] Carlos S. Moreno,et al. Carboxymethylation of the PP2A Catalytic Subunit inSaccharomyces cerevisiae Is Required for Efficient Interaction with the B-type Subunits Cdc55p and Rts1p* , 2001, The Journal of Biological Chemistry.
[33] J. King,et al. Thermolabile folding intermediates: inclusion body precursors and chaperonin substrates , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[34] Theodore W Randolph,et al. Oxidative dimer formation is the critical rate-limiting step for Parkinson's disease alpha-synuclein fibrillogenesis. , 2003, Biochemistry.
[35] M. Manning,et al. Aggregation of recombinant human interferon gamma: kinetics and structural transitions. , 1998, Journal of pharmaceutical sciences.
[36] M. Manning,et al. Chemical and physical pathways of protein degradation , 1992 .
[37] J. Carpenter,et al. A transient expansion of the native state precedes aggregation of recombinant human interferon-gamma. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[38] M. Mulkerrin,et al. pH dependence of the reversible and irreversible thermal denaturation of gamma interferons. , 1989, Biochemistry.
[39] Theodore W Randolph,et al. Roles of conformational stability and colloidal stability in the aggregation of recombinant human granulocyte colony‐stimulating factor , 2003, Protein science : a publication of the Protein Society.
[40] A. Fink,et al. Classification of acid denaturation of proteins: intermediates and unfolded states. , 1994, Biochemistry.
[41] S. Shire,et al. Stability and characterization of recombinant human relaxin. , 1996, Pharmaceutical biotechnology.
[42] D. Hallén,et al. Solvent Effects on the Solubility and Physical Stability of Human Insulin-Like Growth Factor I , 1997, Pharmaceutical Research.
[43] T. Arakawa,et al. Mechanism of protein precipitation and stabilization by co-solvents , 1988 .
[44] T. Österberg,et al. Recombinant factor VIII SQ—influence of oxygen, metal ions, pH and ionic strength on its stability in aqueous solution , 1997 .
[45] Michael Farnum,et al. Effect of glycerol on the interactions and solubility of bovine pancreatic trypsin inhibitor. , 1999, Biophysical journal.
[46] D. Erie,et al. Interpreting the effects of small uncharged solutes on protein-folding equilibria. , 2001, Annual review of biophysics and biomolecular structure.
[47] M. Yu,et al. Folding pathway of human alpha 1-antitrypsin: characterization of an intermediate that is active but prone to aggregation. , 1996, Biochemical and biophysical research communications.
[48] A. Arabshahi,et al. [6] Second virial coefficient as predictor in protein crystal growth. , 1997, Methods in enzymology.
[49] Ronald Wetzel,et al. Amyloid-like features of polyglutamine aggregates and their assembly kinetics. , 2002, Biochemistry.
[50] Wayne R. Gombotz,et al. Interleukin-1 Receptor (IL-1R) Liquid Formulation Development Using Differential Scanning Calorimetry , 1998, Pharmaceutical Research.
[51] M. Hora,et al. Solubility of recombinant human tissue factor pathway inhibitor. , 1999, Journal of Pharmacy and Science.
[52] R. Borchardt,et al. Stability of Protein Pharmaceuticals , 1989, Pharmaceutical Research.
[53] A. Fink. Protein aggregation: folding aggregates, inclusion bodies and amyloid. , 1998, Folding & design.
[54] J. Carpenter,et al. A new mechanism for decreasing aggregation of recombinant human interferon-gamma by a surfactant: slowed dissolution of lyophilized formulations in a solution containing 0.03% polysorbate 20. , 2002, Journal of pharmaceutical sciences.
[55] Theodore W Randolph,et al. Aggregation of granulocyte colony stimulating factor under physiological conditions: characterization and thermodynamic inhibition. , 2002, Biochemistry.
[56] T. Randolph,et al. Molten Globule Intermediate of Recombinant Human Growth Hormone: Stabilization with Surfactants , 1996, Biotechnology progress.
[57] K. Dill,et al. A View of the Hydrophobic Effect , 2002 .
[58] G. Visor,et al. Stability of Interleukin 1β (IL-1β) in Aqueous Solution: Analytical Methods, Kinetics, Products, and Solution Formulation Implications , 1991, Pharmaceutical Research.
[59] J L Cleland,et al. Tween protects recombinant human growth hormone against agitation-induced damage via hydrophobic interactions. , 1998, Journal of pharmaceutical sciences.
[60] C. Dobson,et al. A kinetic study of beta-lactoglobulin amyloid fibril formation promoted by urea. , 2002, Protein science : a publication of the Protein Society.
[61] O. Velev,et al. Protein interactions in solution characterized by light and neutron scattering: comparison of lysozyme and chymotrypsinogen. , 1998, Biophysical journal.
[62] J L Cleland,et al. The development of stable protein formulations: a close look at protein aggregation, deamidation, and oxidation. , 1993, Critical reviews in therapeutic drug carrier systems.
[63] B. Kerwin,et al. Effects of Tween 80 and sucrose on acute short-term stability and long-term storage at -20 degrees C of a recombinant hemoglobin. , 1998, Journal of pharmaceutical sciences.
[64] J. Lee,et al. The stabilization of proteins by sucrose. , 1981, The Journal of biological chemistry.
[65] T. Randolph,et al. Surfactant-Stabilized Protein Formulations: A Review of Protein-Surfactant Interactions and Novel Analytical Methodologies , 1997 .
[66] P. Privalov,et al. Cold Denaturation of Protein , 1990 .
[67] A George,et al. Predicting protein crystallization from a dilute solution property. , 1994, Acta crystallographica. Section D, Biological crystallography.
[68] Chung C. Hsu,et al. Aggregation of recombinant human growth hormone induced by phenolic compounds , 1996 .
[69] I. Apostol,et al. Acute and long-term stability studies of deoxy hemoglobin and characterization of ascorbate-induced modifications. , 1999, Journal of pharmaceutical sciences.
[70] C. Dobson,et al. Dependence on solution conditions of aggregation and amyloid formation by an SH3 domain. , 2001, Journal of molecular biology.
[71] Zamora,et al. Phase behavior of small attractive colloidal particles. , 1996, Physical review letters.
[72] Hydration as a major factor in preferential solvent-protein interactions , 2002 .
[73] Charles F. Morris,et al. Aggregation Pathway of Recombinant Human Keratinocyte Growth Factor and Its Stabilization , 1994, Pharmaceutical Research.
[74] Theodore W Randolph,et al. Surfactant-protein interactions. , 2002, Pharmaceutical biotechnology.
[75] John F. Carpenter,et al. Thermal Stability of Low Molecular Weight Urokinase During Heat Treatment. II. Effect of Polymeric Additives , 1994, Pharmaceutical Research.
[76] J. Carpenter,et al. Partial molar volume, surface area, and hydration changes for equilibrium unfolding and formation of aggregation transition state: High-pressure and cosolute studies on recombinant human IFN-γ , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[77] Y. Yamagata,et al. Contribution of salt bridges near the surface of a protein to the conformational stability. , 2000, Biochemistry.
[78] R. Jaenicke,et al. Protein folding: local structures, domains, subunits, and assemblies. , 1991, Biochemistry.
[79] B. Cunningham,et al. Dimerization of human growth hormone by zinc. , 1991, Science.
[80] J. M. Sanchez-Ruiz,et al. Theoretical analysis of Lumry-Eyring models in differential scanning calorimetry. , 1992, Biophysical journal.
[81] A. D. Robertson,et al. Effects of a naturally occurring compatible osmolyte on the internal dynamics of ribonuclease A. , 1995, Biochemistry.
[82] W. Gombotz,et al. Minimization of recombinant human Flt3 ligand aggregation at the Tm plateau: a matter of thermal reversibility. , 1999, Biochemistry.
[83] M. Manning,et al. Thermodynamic Modulation of Light Chain Amyloid Fibril Formation* , 2000, The Journal of Biological Chemistry.
[84] N. Elvassore,et al. Forces between aqueous nonuniformly charged colloids from molecular simulation , 2002 .
[85] C. Pace,et al. Polar group burial contributes more to protein stability than nonpolar group burial. , 2001, Biochemistry.
[86] Kevin L. Shaw,et al. Increasing protein stability by altering long‐range coulombic interactions , 1999, Protein science : a publication of the Protein Society.
[87] R. Sousa. Use of glycerol, polyols and other protein structure stabilizing agents in protein crystallization. , 1995, Acta crystallographica. Section D, Biological crystallography.
[88] J. Friedman,et al. Time-resolved resonance Raman spectroscopy as probe of structure, dynamics, and reactivity in hemoglobin. , 1994, Methods in enzymology.
[89] T. Patapoff,et al. The Effect of Benzyl Alcohol on Recombinant Human Interferon-γ , 1997, Pharmaceutical Research.
[90] C. Russell Middaugh,et al. Formulation Design of Acidic Fibroblast Growth Factor , 1993, Pharmaceutical Research.
[91] Charles F. Zukoski,et al. Protein interactions and crystallization , 1996 .
[92] W. William Wilson,et al. Relation between the solubility of proteins in aqueous solutions and the second virial coefficient of the solution , 1999 .
[93] G. Barone,et al. A reassessment of the molecular origin of cold denaturation. , 1997, Journal of biochemistry.
[94] M. Manning,et al. Counteracting Effects of Renal Solutes on Amyloid Fibril Formation by Immunoglobulin Light Chains* , 2001, The Journal of Biological Chemistry.
[95] S. Allison,et al. Infrared spectroscopic studies of lyophilization- and temperature-induced protein aggregation. , 1995, Journal of pharmaceutical sciences.
[96] J. Edsall. Hsien Wu and the First Theory of Protein Denaturation (1931) , 1995 .
[97] M. Betenbaugh,et al. II. Electrostatic effect in the aggregation of heat-denatured RNase A and implications for protein additive design. , 1998, Biotechnology and bioengineering.
[98] A. Klibanov,et al. On the role of reversible denaturation (unfolding) in the irreversible thermal inactivation of enzymes , 1983, Biotechnology and bioengineering.
[99] C. Dobson,et al. Unfolding and aggregation during the thermal denaturation of streptokinase. , 2002, European journal of biochemistry.
[100] K. Aoki,et al. Differential scanning calorimetric studies on bovine serum albumin: II. Effects of neutral salts and urea. , 1991, International journal of biological macromolecules.
[101] M C Manning,et al. Inhibition of stress-induced aggregation of protein therapeutics. , 1999, Methods in enzymology.
[102] A. Rosenberg,et al. Structure dynamics of proteins by hydrogen exchange methods. , 1980, Biophysical Journal.
[103] E. Landau,et al. The Hofmeister series: salt and solvent effects on interfacial phenomena , 1997, Quarterly Reviews of Biophysics.
[104] A. Gittis,et al. Protein crystallization by design: chymotrypsinogen without precipitants. , 2000, Journal of molecular biology.
[105] T. Arakawa,et al. Stabilization of recombinant human keratinocyte growth factor by osmolytes and salts. , 1996, Journal of pharmaceutical sciences.
[106] V. Uversky,et al. Effect of salts on the stability and folding of staphylococcal nuclease. , 2001, Biochemistry.
[107] U. Chatterjee,et al. Effect of unconventional feeds on production cost, growth performance and expression of quantitative genes in growing pigs , 2022, Journal of the Indonesian Tropical Animal Agriculture.
[108] W. William Wilson,et al. Correlation of second virial coefficients and solubilities useful in protein crystal growth , 1999 .
[109] S. N. Timasheff,et al. Control of protein stability and reactions by weakly interacting cosolvents: the simplicity of the complicated. , 1998, Advances in protein chemistry.